Rein Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.22

+0.05 (+4.27%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,748.4% upside

Low Target $33.28

Average Target $46.95

High Target $64.49

Current Price $1.22

Current
$1.22

Target
$46.95

$33.28 $46.95 avg $64.49

Scenario Analysis

Bear Case

$33.28

2,627.9%

Low target

Base Case

$46.95

+3,748.4%

Avg target

Bull Case

$64.49

+5,186.1%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.40

-49.2% from high

52-Week Low

$1.00

+22.0% from low

Target vs 52W High

$46.95

+1,856.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%